2018
DOI: 10.1111/imcb.12030
|View full text |Cite
|
Sign up to set email alerts
|

Molecular control of B‐cell homeostasis in health and malignancy

Abstract: Altered B-cell homeostasis underlies a wide range of pathologies, from cancers to autoimmunity and immunodeficiency. The molecular safeguards against those disorders, which also allow effective immune responses, are therefore particularly critical. Here, we review recent findings detailing the fine control of B-cell homeostasis, during B-cell development, maturation in the periphery and during activation and differentiation into antibody-producing cells.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 75 publications
(88 reference statements)
0
6
0
Order By: Relevance
“…Disturbance of B-cell homeostasis and autoantibody production are key hallmarks of pSS ( 30 ). We have previously shown the important role of T FH cells and their IL-21 secretion in autoreactive B cell activation and autoantibody production in pSS ( 26 ).…”
Section: Discussionmentioning
confidence: 99%
“…Disturbance of B-cell homeostasis and autoantibody production are key hallmarks of pSS ( 30 ). We have previously shown the important role of T FH cells and their IL-21 secretion in autoreactive B cell activation and autoantibody production in pSS ( 26 ).…”
Section: Discussionmentioning
confidence: 99%
“…Peripheral B-cells are tightly regulated by the cytokine milieu. Therefore, tumor-related factors could modify the peripheral B-cell compartments [ 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…This could point to a different pathogenetic mechanism for the development of AChR + MG in CLL and underlying peripheral rather than central immune dysregulation. 35 , 36 It may also be that certain genetic and environmental risk factors, for example, genetic risk variants in the PTPN22 and TNFRSF11A loci, predispose these patients to both diseases, (late-onset) AChR + MG and CLL. 36 - 38 In addition, the patient with MG-CLL had antibodies against thyroid peroxidase and a history of vitiligo, but no other autoimmune phenomena were noted, in particular, no anemia or thrombocytopenia ( Table 1 and eTable 2, links.lww.com/NXI/A800 ).…”
Section: Discussionmentioning
confidence: 99%